Abstract
Complicated intraabdominal infections (cIAI) are a common cause of morbidity and mortality in the intensive care unit. Uncomplicated infections do not involve perforation or disruption of the gastrointestinal tract whereas complicated infections are associated with the presence of microbial pathogens in a normal sterile area of the abdomen. They usually manifest as peritonitis and/or abscess formation.
The mainstays of treatment for cIAI include prompt diagnosis, resuscitation, source control and anti-infective therapy. Diagnostic tools include physical exam, computed tomography and ultrasound if a biliary source is suspected. Resuscitation should follow the Surviving Sepsis Campaign guidelines, and is aimed at early goal directed resuscitation with at least 30 mL/kg of intravenous fluid be given within the first 3 h and antimicrobial administration within the first hour after recognition of sepsis and septic shock (Rhodes A, et al. Crit Care Med. 45:486–552, 2017). Source control includes drainage of infected fluid collections, debridement of infected tissue, and definitive measures to control ongoing contamination and restore anatomy and function. Source control can be gained either by operative intervention or percutaneous drainage.
At a minimum, antimicrobial therapy should empirically cover common gram negative Enterobacteriaceae and enteric anaerobes. For patients with health-care-associated infections, broader-spectrum agents having activity against resistant gram negative flora such as Pseudomonas aeruginosa and Acinetobacter sp., enterococci, occasionally methicillin-resistant staphylococci, and yeast may be needed as well. Specific therapies should be guided by hospital and ICU antibiograms.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552.
Mazuski JE, Tessier J, May AK, Sawyer RG, Nadler EP, Rosengart MR, et al. The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect. 2017;18(1):1–76.
Crandall M, West MA. Evaluation of the abdomen in the critically ill patient: opening the black box. Curr Opin Crit Care. 2006;12(4):333–9.
Pieracci FM, Barie PS. Management of severe sepsis of abdominal origin. Scand J Surg. 2007;96(3):184–96.
Shirah GR, O’Neill PJ. Intra-abdominal infections. Surg Clin North Am. 2014;94(6):1319–33.
Noone TC, Semelka RC, Chaney DM, Reinhold C. Abdominal imaging studies: comparison of diagnostic accuracies resulting from ultrasound, computed tomography, and magnetic resonance imaging in the same individual. Magn Reson Imaging. 2004;22(1):19–24.
Lopez N, Kobayashi L, Coimbra R. A comprehensive review of abdominal infections. World J Emerg Surg. 2011;6:7.
Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004;32(11 Suppl):S513–26.
Koperna T, Schulz F. Relaparotomy in peritonitis: prognosis and treatment of patients with persisting intraabdominal infection. World J Surg. 2000;24(1):32–7.
Waibel BH, Rotondo MF. Damage control for intra-abdominal sepsis. Surg Clin North Am. 2012;92(2):243–57.
Weber DG, Bendinelli C, Balogh ZJ. Damage control surgery for abdominal emergencies. Br J Surg. 2014;101(1):e109–18.
van Ruler O, Mahler CW, Boer KR, Reuland EA, Gooszen HG, Opmeer BC, et al. Comparison of on-demand vs planned relaparotomy strategy in patients with severe peritonitis; a randomized trial. JAMA. 2007;298(8):865–72.
Akinci D, Akhan O, Ozmen MN, Karabulut N, Ozkan O, Cil BE, et al. Percutaneous drainage of 300 intraperitoneal abscesses with long-term follow up. Cardiovasc Intervent Radiol. 2005;28(6):744–50.
Hemming A, Davis NL, Robins RE. Surgical versus percutaneous drainage of intra-abdominal abscesses. Am J Surg. 1991;161(5):593–5.
Sartelli M, Abu-Zidan FM, Ansaloni L, Bala M, Beltrán MA, Biffl WL, et al. The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper. World J Emerg Surg. 2015;10:35.
Bruns BR, Ahmad SA, O’Meara L, Tesoriero R, Lauerman M, Klyushnenkova E, et al. Nontrauma open abdomens: a prospective observational study. J Trauma Acute Care Surg. 2016;80(4):631–6.
Open Abdomen Advisory Panel, Campbell A, Chang M, Fabian T, Franz M, Kaplan M, Moore F, et al. Management of the open abdomen: from initial operation to definitive closure. Am Surg. 2009;75(11 Suppl):S1–S22.
Carlson GL, Patrick H, Amin AI, McPherson G, MacLennan G, Afolabi E, et al. Management of the open abdomen: a national study of clinical outdome and safety of negative pressure wound therapy. Ann Surg. 2013;257(6):1154–9.
Coccolini F, Biffl W, Catena F, Ceresoli M, Chiara O, Cimbanassi S, et al. The open abdomen, indications, management and definitive closure. World J Emerg Surg. 2015;10:32.
Sartelli M, Catena F, Ansaloni L, Coccolini F, Corbella D, Moore EE, et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW study. World J Emerg Surg. 2014;9:37.
Coccolini F, Montori G, Ceresoli M, Catena F, Moore EE, Ivatury R, et al. The role of the open abdomen in non-trauma patient: WSES consensus paper. World J Emerg Surg. 2017;12:39.
Bassetti M, Righi E, Ansaldi F, Merelli M, Scarparo C, Antonelli M, Garnacho-Montero J, Diaz-Martin A, Palacios-Garcia I, Luzzati R, Rosin C, Lagunes L, Rello J, Almirante B, Scotton PG, Baldin G, Dimopoulos G, Nucci M, Munoz P, Vena A, Bouza E, de Egea V, Colombo AL, Tascini C, Menichetti F, Tagliaferri E, Brugnaro P, Sanguinetti M, Mesini A, Sganga G, Viscoli C, Tumbarello M. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. 2015;41(9):1601–10.
Soop M, Carlson GL. Recent developments in the surgical management of complex intra-abdominal infection. Br J Surg. 2017;104(2):e65–74.
Montravers P, Dupont H, Gauzit R, Verber B, Auboyer C, Blin P, et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med. 2006;34(3):646–52.
Zilberberg M, Yu HT, Chaudhari P, Emons MF, Khandelwal N, Shorr AF. Relationship of fluconazole prophylaxis with fungal microbiology in hospitalized intra-abdominal surgery patients: a descriptive cohort study. Crit Care. 2014;18(5):590.
Vergidis P, Clancy CJ, Shields RK, Park SY, Wildfeuer BN, Simmons RL, et al. Intra-abdominal candidiasis: the importance of early source control and antifungal treatment. PLoS One. 2016;11(4):e0153247.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Buckman, S.A., Mazuski, J.E. (2020). Abdominal Sepsis and Complicated Intraabdominal Infections. In: Hyzy, R.C., McSparron, J. (eds) Evidence-Based Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-030-26710-0_87
Download citation
DOI: https://doi.org/10.1007/978-3-030-26710-0_87
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26709-4
Online ISBN: 978-3-030-26710-0
eBook Packages: MedicineMedicine (R0)